• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

皱落假丝酵母菌,一种对唑类耐药的新兴真菌病原体:来自ARTEMIS DISK抗真菌监测项目的地理和时间趋势

Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.

作者信息

Pfaller M A, Diekema D J, Colombo A L, Kibbler C, Ng K P, Gibbs D L, Newell V A

机构信息

Medical Microbiology Division, C606 GH, Department of Pathology, University of Iowa College of Medicine, Iowa City, IA 52242, USA.

出版信息

J Clin Microbiol. 2006 Oct;44(10):3578-82. doi: 10.1128/JCM.00863-06.

DOI:10.1128/JCM.00863-06
PMID:17021085
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC1594768/
Abstract

Candida rugosa is a fungus that appears to be emerging as a cause of infection in some geographic regions. We utilized the extensive database of the ARTEMIS DISK Antifungal Surveillance Program to describe the geographic and temporal trends in the isolation of C. rugosa from clinical specimens and the in vitro susceptibilities of 452 isolates to fluconazole and voriconazole. C. rugosa accounted for 0.4% of 134,715 isolates of Candida, and the frequency of isolation increased from 0.03% to 0.4% over the 6.5-year study period (1997 to 2003). C. rugosa was most common in the Latin American region (2.7% versus 0.1 to 0.4%). Decreased susceptibility to fluconazole (40.5% susceptible) was observed in all geographic regions; however, isolates from Europe and North America were much more susceptible (97 to 100%) to voriconazole than those from other geographic regions (55.8 to 58.8%). C. rugosa was most often isolated from blood and urine in patients hospitalized at the Medical and Surgical inpatient services. Notably, bloodstream isolates were the least susceptible to both fluconazole and voriconazole. C. rugosa should be considered, along with the established pathogens Candida krusei and Candida glabrata, as a species of Candida with reduced susceptibility to the azole antifungal agents.

摘要

皱落假丝酵母菌是一种在某些地理区域似乎正逐渐成为感染源的真菌。我们利用ARTEMIS DISK抗真菌监测项目的广泛数据库,来描述从临床标本中分离出皱落假丝酵母菌的地理和时间趋势,以及452株分离株对氟康唑和伏立康唑的体外敏感性。皱落假丝酵母菌占134715株假丝酵母菌分离株的0.4%,在6.5年的研究期(1997年至2003年)内,分离频率从0.03%增至0.4%。皱落假丝酵母菌在拉丁美洲地区最为常见(2.7%,而其他地区为0.1%至0.4%)。在所有地理区域均观察到对氟康唑的敏感性降低(40.5%敏感);然而,来自欧洲和北美的分离株对伏立康唑的敏感性(97%至100%)远高于其他地理区域的分离株(55.8%至58.8%)。皱落假丝酵母菌最常从内科和外科住院患者的血液和尿液中分离得到。值得注意的是,血流分离株对氟康唑和伏立康唑的敏感性最低。皱落假丝酵母菌应与已明确的病原菌克鲁斯假丝酵母菌和光滑假丝酵母菌一起,被视为对唑类抗真菌药物敏感性降低的假丝酵母菌菌种。

相似文献

1
Candida rugosa, an emerging fungal pathogen with resistance to azoles: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.皱落假丝酵母菌,一种对唑类耐药的新兴真菌病原体:来自ARTEMIS DISK抗真菌监测项目的地理和时间趋势
J Clin Microbiol. 2006 Oct;44(10):3578-82. doi: 10.1128/JCM.00863-06.
2
Geographic variation in the frequency of isolation and fluconazole and voriconazole susceptibilities of Candida glabrata: an assessment from the ARTEMIS DISK Global Antifungal Surveillance Program.地理区域差异对光滑念珠菌分离频率及氟康唑和伏立康唑药敏性的影响:来自 ARTEMIS DISK 全球抗真菌监测项目的评估。
Diagn Microbiol Infect Dis. 2010 Jun;67(2):162-71. doi: 10.1016/j.diagmicrobio.2010.01.002. Epub 2010 Mar 24.
3
Geographic and temporal trends in isolation and antifungal susceptibility of Candida parapsilosis: a global assessment from the ARTEMIS DISK Antifungal Surveillance Program, 2001 to 2005.近平滑念珠菌的分离情况及抗真菌药敏的地理和时间趋势:2001年至2005年ARTEMIS DISK抗真菌监测项目的全球评估
J Clin Microbiol. 2008 Mar;46(3):842-9. doi: 10.1128/JCM.02122-07. Epub 2008 Jan 16.
4
Results from the ARTEMIS DISK Global Antifungal Surveillance study, 1997 to 2005: an 8.5-year analysis of susceptibilities of Candida species and other yeast species to fluconazole and voriconazole determined by CLSI standardized disk diffusion testing.1997年至2005年ARTEMIS DISK全球抗真菌监测研究结果:一项对念珠菌属及其他酵母菌种对氟康唑和伏立康唑敏感性的8.5年分析,采用CLSI标准化纸片扩散法检测。
J Clin Microbiol. 2007 Jun;45(6):1735-45. doi: 10.1128/JCM.00409-07. Epub 2007 Apr 18.
5
Candida guilliermondii, an opportunistic fungal pathogen with decreased susceptibility to fluconazole: geographic and temporal trends from the ARTEMIS DISK antifungal surveillance program.季也蒙念珠菌,一种对氟康唑敏感性降低的机会性真菌病原体:来自ARTEMIS DISK抗真菌监测项目的地理和时间趋势
J Clin Microbiol. 2006 Oct;44(10):3551-6. doi: 10.1128/JCM.00865-06.
6
Activities of fluconazole and voriconazole against bloodstream isolates of Candida glabrata and Candida krusei: a 14-year study in a Spanish tertiary medical centre.氟康唑和伏立康唑对光滑念珠菌和克柔念珠菌血流分离株的活性:西班牙一家三级医疗中心的14年研究。
Int J Antimicrob Agents. 2008 Mar;31(3):266-71. doi: 10.1016/j.ijantimicag.2007.09.010. Epub 2007 Dec 3.
7
In vitro activity of fluconazole and voriconazole against clinical isolates of Candida spp. by E-test method.采用E-test法检测氟康唑和伏立康唑对念珠菌属临床分离株的体外活性。
Trop Biomed. 2010 Aug;27(2):200-7.
8
In vitro activity of voriconazole against Candida species isolated in Taiwan.伏立康唑对台湾分离出的念珠菌属的体外活性。
Int J Antimicrob Agents. 2004 Sep;24(3):294-6. doi: 10.1016/j.ijantimicag.2004.01.014.
9
Results from the ARTEMIS DISK Global Antifungal Surveillance Study, 1997 to 2007: a 10.5-year analysis of susceptibilities of Candida Species to fluconazole and voriconazole as determined by CLSI standardized disk diffusion.ARTEMIS DISK 全球抗真菌监测研究结果,1997 年至 2007 年:10.5 年时间内通过 CLSI 标准化纸片扩散法测定的念珠菌属对氟康唑和伏立康唑的药敏性分析。
J Clin Microbiol. 2010 Apr;48(4):1366-77. doi: 10.1128/JCM.02117-09. Epub 2010 Feb 17.
10
National surveillance of species distribution in blood isolates of Candida species in Japan and their susceptibility to six antifungal agents including voriconazole and micafungin.日本念珠菌属血液分离株的物种分布及其对包括伏立康唑和米卡芬净在内的六种抗真菌药物的敏感性的全国监测。
J Antimicrob Chemother. 2004 Feb;53(2):283-9. doi: 10.1093/jac/dkh053. Epub 2003 Dec 19.

引用本文的文献

1
Thymol-Modified Oleic and Linoleic Acids Encapsulated in Polymeric Nanoparticles: Enhanced Bioactivity, Stability, and Biomedical Potential.包裹于聚合物纳米颗粒中的百里酚修饰油酸和亚油酸:增强的生物活性、稳定性及生物医学潜力
Polymers (Basel). 2023 Dec 26;16(1):72. doi: 10.3390/polym16010072.
2
Meyerozyma guilliermondii species complex: review of current epidemiology, antifungal resistance, and mechanisms.梅伊罗泽姆酵母种复合体:当前流行病学、抗真菌耐药性和机制的综述。
Braz J Microbiol. 2022 Dec;53(4):1761-1779. doi: 10.1007/s42770-022-00813-2. Epub 2022 Oct 28.
3
Isolation Frequency of Fluconazole-Resistant Candida Species From Cockroaches: A Cross-Sectional Study From a National Hospital in Dar es Salaam, Tanzania.从蟑螂中分离出耐氟康唑念珠菌属的频率:坦桑尼亚达累斯萨拉姆一家国立医院的横断面研究
Cureus. 2022 Apr 23;14(4):e24412. doi: 10.7759/cureus.24412. eCollection 2022 Apr.
4
Genome Assemblies of Two Rare Opportunistic Yeast Pathogens: (syn. ) and (syn. ).两种罕见机会性酵母病原体的基因组组装:(同物异名:)和(同物异名:)。
G3 (Bethesda). 2019 Dec 3;9(12):3921-3927. doi: 10.1534/g3.119.400762.
5
Dual DNA Barcoding for the Molecular Identification of the Agents of Invasive Fungal Infections.用于侵袭性真菌感染病原体分子鉴定的双DNA条形码技术
Front Microbiol. 2019 Jul 18;10:1647. doi: 10.3389/fmicb.2019.01647. eCollection 2019.
6
Prevalence of bloodstream isolates from patients in two hospitals in Vietnam.越南两家医院患者血液分离株的流行情况。
Iran J Microbiol. 2019 Apr;11(2):108-113.
7
Microbial diversity in two traditional bacterial douchi from Gansu province in northwest China using Illumina sequencing.采用 Illumina 测序技术研究中国西北地区甘肃省两种传统细菌豆食中的微生物多样性。
PLoS One. 2018 Mar 23;13(3):e0194876. doi: 10.1371/journal.pone.0194876. eCollection 2018.
8
Epidemiology of fungal infections in China.中国真菌感染的流行病学。
Front Med. 2018 Feb;12(1):58-75. doi: 10.1007/s11684-017-0601-0. Epub 2018 Jan 11.
9
Invasive Candidiasis in Brescia, Italy: Analysis of Species Distribution and Antifungal Susceptibilities During Seven Years.意大利布雷西亚侵袭性念珠菌病:七年种属分布和抗真菌药敏分析。
Mycopathologia. 2017 Oct;182(9-10):897-905. doi: 10.1007/s11046-017-0155-3. Epub 2017 Jun 8.
10
High Virulence and Antifungal Resistance in Clinical Strains of ..临床菌株中的高毒力和抗真菌耐药性
Can J Infect Dis Med Microbiol. 2016;2016:5930489. doi: 10.1155/2016/5930489. Epub 2016 Dec 12.

本文引用的文献

1
Interpretive breakpoints for fluconazole and Candida revisited: a blueprint for the future of antifungal susceptibility testing.氟康唑与念珠菌的解释性折点再探讨:抗真菌药敏试验未来的蓝图。
Clin Microbiol Rev. 2006 Apr;19(2):435-47. doi: 10.1128/CMR.19.2.435-447.2006.
2
Correlation of MIC with outcome for Candida species tested against voriconazole: analysis and proposal for interpretive breakpoints.针对念珠菌属对伏立康唑的药敏试验,最小抑菌浓度(MIC)与结果的相关性分析及解释性折点建议
J Clin Microbiol. 2006 Mar;44(3):819-26. doi: 10.1128/JCM.44.3.819-826.2006.
3
Current treatment strategies for disseminated candidiasis.播散性念珠菌病的当前治疗策略。
Clin Infect Dis. 2006 Jan 15;42(2):244-51. doi: 10.1086/499057. Epub 2005 Dec 2.
4
Results from the ARTEMIS DISK Global Antifungal Surveillance Study: a 6.5-year analysis of susceptibilities of Candida and other yeast species to fluconazole and voriconazole by standardized disk diffusion testing.ARTEMIS DISK全球抗真菌监测研究结果:通过标准化纸片扩散试验对念珠菌及其他酵母菌种对氟康唑和伏立康唑敏感性的6.5年分析。
J Clin Microbiol. 2005 Dec;43(12):5848-59. doi: 10.1128/JCM.43.12.5848-5859.2005.
5
Relationship between MIC and minimum sterol 14{alpha}-demethylation-inhibitory concentration as a factor in evaluating activities of azoles against various fungal species.作为评估唑类药物对各种真菌活性的一个因素,最小抑菌浓度(MIC)与最小甾醇14α-去甲基化抑制浓度之间的关系。
J Clin Microbiol. 2005 Nov;43(11):5547-9. doi: 10.1128/JCM.43.11.5547-5549.2005.
6
Comparison of results of voriconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.伏立康唑纸片扩散法检测念珠菌属的结果与ARTEMIS全球抗真菌监测项目中一家中央参考实验室的结果比较。
J Clin Microbiol. 2005 Oct;43(10):5208-13. doi: 10.1128/JCM.43.10.5208-5213.2005.
7
Emerging fungal diseases.新出现的真菌病
Clin Infect Dis. 2005 Aug 15;41(4):521-6. doi: 10.1086/432060. Epub 2005 Jul 11.
8
Rare and emerging opportunistic fungal pathogens: concern for resistance beyond Candida albicans and Aspergillus fumigatus.罕见及新出现的机会性真菌病原体:对白色念珠菌和烟曲霉之外的耐药性的关注。
J Clin Microbiol. 2004 Oct;42(10):4419-31. doi: 10.1128/JCM.42.10.4419-4431.2004.
9
Comparison of results of fluconazole disk diffusion testing for Candida species with results from a central reference laboratory in the ARTEMIS global antifungal surveillance program.在ARTEMIS全球抗真菌监测项目中,将念珠菌属的氟康唑纸片扩散法检测结果与一家中央参考实验室的结果进行比较。
J Clin Microbiol. 2004 Aug;42(8):3607-12. doi: 10.1128/JCM.42.8.3607-3612.2004.
10
Guidelines for treatment of candidiasis.念珠菌病治疗指南。
Clin Infect Dis. 2004 Jan 15;38(2):161-89. doi: 10.1086/380796. Epub 2003 Dec 19.